255 related articles for article (PubMed ID: 24185760)
1. Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis.
Chandran V; Bull SB; Pellett FJ; Ayearst R; Pollock RA; Gladman DD
Rheumatology (Oxford); 2014 Feb; 53(2):233-9. PubMed ID: 24185760
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen alleles and susceptibility to psoriatic arthritis.
Chandran V; Bull SB; Pellett FJ; Ayearst R; Rahman P; Gladman DD
Hum Immunol; 2013 Oct; 74(10):1333-8. PubMed ID: 23916976
[TBL] [Abstract][Full Text] [Related]
3. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
4. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
6. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis.
Eder L; Chandran V; Pellet F; Shanmugarajah S; Rosen CF; Bull SB; Gladman DD
Ann Rheum Dis; 2012 Jan; 71(1):50-5. PubMed ID: 21900282
[TBL] [Abstract][Full Text] [Related]
7. Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.
Lowe DP; Cook MA; Bowman SJ; Briggs DC;
Rheumatology (Oxford); 2009 Apr; 48(4):359-62. PubMed ID: 19181658
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.
Martin MP; Nelson G; Lee JH; Pellett F; Gao X; Wade J; Wilson MJ; Trowsdale J; Gladman D; Carrington M
J Immunol; 2002 Sep; 169(6):2818-22. PubMed ID: 12218090
[TBL] [Abstract][Full Text] [Related]
9. Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.
Middleton D; Diler AS; Meenagh A; Sleator C; Gourraud PA
Tissue Antigens; 2009 Jun; 73(6):553-60. PubMed ID: 19493232
[TBL] [Abstract][Full Text] [Related]
10. Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.
Kuśnierczyk P; Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Bereszyńska I; Pauli A; Żeromski J
Hum Immunol; 2015 Mar; 76(2-3):102-8. PubMed ID: 25636579
[TBL] [Abstract][Full Text] [Related]
11. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis.
Gonzalez S; Martinez-Borra J; Torre-Alonso JC; Gonzalez-Roces S; Sanchez del Río J; Rodriguez Pérez A; Brautbar C; López-Larrea C
Arthritis Rheum; 1999 May; 42(5):1010-6. PubMed ID: 10323458
[TBL] [Abstract][Full Text] [Related]
12. Association of variably expressed KIR3dl1 alleles with psoriatic disease.
Berinstein J; Pollock R; Pellett F; Thavaneswaran A; Chandran V; Gladman DD
Clin Rheumatol; 2017 Oct; 36(10):2261-2266. PubMed ID: 28801811
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
14. The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms.
Nourse JP; Lea R; Crooks P; Wright G; Tran H; Catalano J; Brighton T; Grigg A; Marlton P; Gandhi MK
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):45-50. PubMed ID: 22024796
[TBL] [Abstract][Full Text] [Related]
15. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
[TBL] [Abstract][Full Text] [Related]
16. Association Study between Psoriatic Arthritis and Killer Immunoglobulin-Like Receptor (
Enciso-Vargas M; Alvarado-Ruíz L; Suárez-Villanueva AS; Macías-Barragán J; Montoya-Buelna M; Oceguera-Contreras E; Alvarado-Navarro A; Graciano-Machuca O
Immunol Invest; 2021 Feb; 50(2-3):152-163. PubMed ID: 31957514
[No Abstract] [Full Text] [Related]
17. Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.
Sanjeevi S; Sun C; Kanungo A; Sanjeevi CB
Diabet Med; 2016 Jan; 33(1):91-6. PubMed ID: 26031759
[TBL] [Abstract][Full Text] [Related]
18. Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study.
Eder L; Chandran V; Pellett F; Shanmugarajah S; Rosen CF; Bull SB; Gladman DD
Ann Rheum Dis; 2012 Aug; 71(8):1361-5. PubMed ID: 22586163
[TBL] [Abstract][Full Text] [Related]
19. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
[TBL] [Abstract][Full Text] [Related]
20. Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.
Salim PH; Jobim M; Bredemeier M; Chies JA; Schlottfeldt J; Brenol JC; Jobim LF; Xavier RM
Clin Exp Immunol; 2010 Jun; 160(3):325-30. PubMed ID: 20082621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
